Literature DB >> 21546254

Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles.

Abhijit Datta Khoje1, Colin Charnock, Baojie Wan, Scott Franzblau, Lise-Lotte Gundersen.   

Abstract

6,9-Disubstituted purines and 7-deazapurines are known to be powerful inhibitors of Mycobacterium tuberculosis (Mtb) in vitro. Analogs modified in the six-membered ring (imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles) were synthesized and evaluated as Mtb inhibitors. The targets were prepared by functionalization on the bicyclic heterocycle or from simple pyridines. The results reported herein, indicate that the purine N-1, but not N-3, is important for binding to the unknown target. The 3-deazapurines appears to be slightly more active compared to the parent purines and slightly less active than their 7-deazapurine isomers. Removal of both the purine N-3 and N-7 did not result in further enhanced antimycobacterial activity but the toxicity towards mammalian cells was increased. Both 3-deaza and 3,7-dideazapurines exhibited a modest activity against of the Mtb isolate in the state of non-replicating persistence.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21546254     DOI: 10.1016/j.bmc.2011.04.023

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  6-Oxo and 6-thio purine analogs as antimycobacterial agents.

Authors:  Ashish K Pathak; Vibha Pathak; Lainne E Seitz; William J Suling; Robert C Reynolds
Journal:  Bioorg Med Chem       Date:  2013-02-04       Impact factor: 3.641

2.  Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis.

Authors:  Kriti Arora; Bernardo Ochoa-Montaño; Patricia S Tsang; Tom L Blundell; Stephanie S Dawes; Valerie Mizrahi; Tracy Bayliss; Claire J Mackenzie; Laura A T Cleghorn; Peter C Ray; Paul G Wyatt; Eugene Uh; Jinwoo Lee; Clifton E Barry; Helena I Boshoff
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 3.  Inhibiting Mycobacterium tuberculosis within and without.

Authors:  Stewart T Cole
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-11-05       Impact factor: 6.237

4.  A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis.

Authors:  Puiying A Mak; Srinivasa P S Rao; Mai Ping Tan; Xiuhua Lin; Jason Chyba; Joann Tay; Seow Hwee Ng; Bee Huat Tan; Joseph Cherian; Jeyaraj Duraiswamy; Pablo Bifani; Vivian Lim; Boon Heng Lee; Ngai Ling Ma; David Beer; Pamela Thayalan; Kelli Kuhen; Arnab Chatterjee; Frantisek Supek; Richard Glynne; Jun Zheng; Helena I Boshoff; Clifton E Barry; Thomas Dick; Kevin Pethe; Luis R Camacho
Journal:  ACS Chem Biol       Date:  2012-04-25       Impact factor: 5.100

5.  Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis.

Authors:  Mohana Rao Anguru; Ashok Kumar Taduri; Rama Devi Bhoomireddy; Malathi Jojula; Shravan Kumar Gunda
Journal:  Chem Cent J       Date:  2017-07-24       Impact factor: 4.215

Review 6.  Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.

Authors:  Malwina Krause; Henryk Foks; Katarzyna Gobis
Journal:  Molecules       Date:  2017-03-04       Impact factor: 4.411

7.  Synthesis and Biological Evaluation of 1,3-Dideazapurine-Like 7-Amino-5-Hydroxymethyl-Benzimidazole Ribonucleoside Analogues as Aminoacyl-tRNA Synthetase Inhibitors.

Authors:  Baole Zhang; Luping Pang; Manesh Nautiyal; Steff De Graef; Bharat Gadakh; Eveline Lescrinier; Jef Rozenski; Sergei V Strelkov; Stephen D Weeks; Arthur Van Aerschot
Journal:  Molecules       Date:  2020-10-16       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.